Resources

Resources

Pharma Channel Insights: Asembia 2023 and Beyond

OnDemand

From the rising costs of distribution and dispensing obstacles to the growing presence of digital pharmacies, direct distribution, and alternative networks, pharmaceutical organizations are trying to pivot in this new environment. IntegriChain and Blue Fin Group channel experts Dave Weiss, Vice President of Industry Solutions and Bill Roth, General Manager and Founding Partner, discussed how leading pharma manufacturers are re-assessing their channel design, data, and operational capabilities needed to respond with agility. 

Request a copy of the recording by emailing


Davev2 200x200 Philly New 2020
Dave Weiss
Vice President, Industry Solutions


Bill Roth
Bill Roth
General Manager and Founding Partner, Blue Fin Group


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article